Last Round
Series B++
Jun 5, 2026
Total Funding Raised
$6.29M
Company Overview
Jiajin Biopharmaceutical (Shanghai) Co., Ltd. is a biotechnology company that specializes in antibody-small nucleic acid coupled drugs and brain-delivery platforms for the treatment of genetic and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Jiajin Biopharmaceutical (Shanghai) Co., Ltd. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Jiajin Biopharmaceutical (Shanghai) Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B++ | Jun 5, 2026 | ||||
| Series B Extension | Dec 26, 2025 | ||||
| Series B | Aug 19, 2025 | ||||
| Series A++ | Apr 3, 2025 | ||||
| Series A Extension | Nov 8, 2024 | ||||
Series A | Jun 15, 2024 |
Jiajin Biopharmaceutical (Shanghai) Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shanghai Science & Technology Venture Capital (Group) | Series B++ |
| Legend Capital | Series B Extension, Series B++ |
| Frees Fund | Series B++, Angel |
| Sunshine Insurance Group | Series B++, Series B |
| MPC | Series B++, Angel |
| Lilly Asia Ventures | Series B++ |
| Qingsong Capital | Series B++ |
Jiajin Biopharmaceutical (Shanghai) Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Jiajin Biopharmaceutical (Shanghai) Co., Ltd.'s valuation, stock price, and market status.